Perspectives in pharmacology of endothelium: From bench to bedside

Pharmacological Reports

Volumn 67, Issue 4, 2015, Pages vi-ix

  Chlopicki, Stefan ^a,b  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; ADENOSINE; ENDOTHELIN 1; NITRIC OXIDE;

BIOMEDICINE; HUMAN; METHODOLOGY; REVIEW; TOXICITY TESTING; VASCULAR ENDOTHELIUM; DRUG EFFECTS; METABOLISM; POINT OF CARE SYSTEM; TRENDS;

ADENOSINE; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; HUMANS; NITRIC OXIDE; POINT-OF-CARE SYSTEMS;

EID: 84940403807     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/j.pharep.2015.08.005     Document Type: Editorial

References (38)

1. H. Florey Exchange of substances between the blood and tissues Nature 192 1961 908 912
2. W.C. Aird Endothelial cell heterogeneity Cold Spring Harb Perspect Med 2 2012 a006429
3. W.C. Aird Endothelium as a therapeutic target in sepsis Curr Drug Targets 8 2007 501 507
4. S. Chlopicki, and R.J. Gryglewski Angiotensin converting enzyme (ACE) and HydroxyMethylGlutaryl-CoA (HMG-CoA) reductase inhibitors in the forefront of pharmacology of endothelium Pharmacol Rep 57 Suppl 2005 86 96
5. D.G. Della Rocca, and C.J. Pepine Endothelium as a predictor of adverse outcomes Clin Cardiol 33 2010 730 732
6. M.A. Gimbrone Jr., M.I. Cybulsky, N. Kume, T. Collins, and N. Resnick Vascular endothelium. An integrator of pathophysiological stimuli in atherogenesis Ann N Y Acad Sci 748 1995 122 131
7. R.J. Gryglewski Pharmacology of vascular endothelium. Delivered on 27 June 2004 at the 29th FEBS Congress in Warsaw FEBS J 272 2005 2956 2967
8. Y. Matsuzawa, R.R. Guddeti, T.G. Kwon, L.O. Lerman, and A. Lerman Treating coronary disease and the impact of endothelial dysfunction Prog Cardiovasc Dis 57 2015 431 442
9. A.A. Quyyumi Endothelial function in health and disease: new insights into the genesis of cardiovascular disease Am J Med 105 1998 32S 39S
10. P. Rajendran, T. Rengarajan, J. Thangavel, Y. Nishigaki, D. Sakthisekaran, G. Sethi, and I. Nishigaki The vascular endothelium and human diseases Int J Biol Sci 9 2013 1057 1069
11. J.A. Vita, and J.F. Keaney Jr. Endothelial function: a barometer for cardiovascular risk? Circulation 106 2002 640 642
12. R.F. Furchgott The 1996 Albert Lasker Medical Research Awards. The discovery of endothelium-derived relaxing factor and its importance in the identification of nitric oxide JAMA 276 1996 1186 1188
13. R.J. Gryglewski Prostacyclin among prostanoids Pharmacol Rep 60 2008 3 11
14. J.R. Vane The Croonian Lecture, 1993. The endothelium: maestro of the blood circulation Philos Trans R Soc Lond B Biol Sci 343 1994 225 246
15. A.J. Flammer, T. Anderson, D.S. Celermajer, M.A. Creager, J. Deanfield, P. Ganz, N.M. Hamburg, T.F. Luscher, M. Shechter, S. Taddei, J.A. Vita, and A. Lerman The assessment of endothelial function: from research into clinical practice Circulation 126 2012 753 767
16. W.C. Aird. W.C. Aird, Endothelial biomedicine 1st ed. 2007 Cambridge University Press
17. E.E. Kelley A New paradigm for XOR-catalyzed reactive species generation in the endothelium Pharmacol Rep. 67 4 2015 669 674
18. P. Zukowska, B. Kutryb-Zajac, M. Toczek, R.T. Smolenski, and E.M. Slominska The role of ecto-5′-nucleotidase in endothelial dysfunction and vascular pathologies Pharmacol Rep 67 4 2015 675 681
19. M.A. Zabielska, T. Borkowski, E.M. Slominska, and R.T. Smolenski Inhibition of AMP deaminase as therapeutic target in cardiovascular pathology Pharmacol Rep 67 4 2015 682 688
20. E. Maslak, A. Gregorius, and S. Chlopicki Liver sinusoidal endothelial cells (LSECs) function and NAFLD; NO based therapy targeted to the liver Pharmacol Rep 67 4 2015 689 694
21. K. Kramkowski, A. Leszczynska, and W. Buczko Pharmacological modulation of fibrinolytic response - in vivo and in vitro studies Pharmacol Rep 67 4 2015 695 703
22. A. Szewczyk, W. Jarmuszkiewicz, A. Koziel, I. Sobieraj, W. Nobik, A. Lukasiak, and et al. Mitochondrial mechanisms of endothelial dysfunction Pharmacol Rep 67 4 2015 704 710
23. A. Blazejczyk, D. Papiernik, K. Porshneva, J. Sadowska, and J. Wietrzyk Endothelium and cancer metastasis: perspectives for antimetastatic therapy Pharmacol Rep 67 4 2015 711 718
24. J.A. Zoladz, J. Majerczak, K. Duda, and S. Chlopicki Coronary and muscle blood flow during physical exercise in humans: heterogenic alliance Pharmacol Rep 67 4 2015 719 727
25. M. Szymonski, M. Targosz-Korecka, and K.E. Malek-Zietek Nano-mechanical model of endothelial dysfunction for AFM-based diagnostics at the cellular level Pharmacol Rep 67 4 2015 728 735
26. M. Baranska, A. Kaczor, K. Malek, A. Jaworska, K. Majzner, E. Staniszewska-Slezak, and et al. Raman microscopy as a novel tool to detect endothelial dysfunction Pharmacol Rep 67 4 2015 736 743
27. K.M. Marzec, A. Rygula, M. Gasior-Glogowska, K. Kochan, K. Czamara, K. Bulat, and et al. Vascular diseases investigated ex vivo by using Raman. FT-IR and complementary methods Pharmacol Rep 67 4 2015 744 750
28. S. Zapotoczny, K. Szczubialka, and M. Nowakowska Nanoparticles in endothelial theranostics Pharmacol Rep 67 4 2015 751 755
29. K. Debowska, D. Debski, M. Hardy, M. Jakubowska, B. Kalyanaraman, A. Marcinek, and et al. Towards selective detection of reactive oxygen and nitrogen species with the use of fluorogenic probes - limitations, progress, and perspectives Pharmacol Rep 67 4 2015 756 764
30. A. Bar, T. Skorka, K. Jasinski, and S. Chlopicki MRI-based assessment of endothelial dysfunction in animal models in vivo Pharmacol Rep 67 4 2015 765 770
31. M. Walczak, J. Suraj, K. Kus, A. Kij, A. Zakrzewska, and S. Chlopicki Towards comprehensive endothelial biomarkers profiling and endothelium guided pharmacotherapy Pharmacol Rep 67 4 2015 771 777
32. M. Olkowicz, S. Chlopicki, and R.T. Smolenski Perspectives for angiotensin profiling with liquid chromatography/mass spectrometry to evaluate ACE/ACE2 balance in endothelial dysfunction and vascular pathologies Pharmacol Rep 67 4 2015 778 785
33. M. Frolow, A. Drozdz, A. Kowalewska, R. Nizankowski, and S. Chlopicki Comprehensive assessment of vascular health in patients; towards endothelium-guided therapy Pharmacol Rep 67 4 2015 786 792
34. N. Kachamakova-Trojanowska, K. Bukowska-Strakova, M. Zukowska, J. Dulak, and A. Jozkowicz The real face of endothelial progenitor cells - circulating angiogenic cells as endothelial prognostic marker? Pharmacol Rep 67 4 2015 793 802
35. M. Hellmann, M. Roustit, and J.-L. Cracowski Skin microvascular endothelial function as a biomarker in cardiovascular diseases? Pharmacol Rep 67 4 2015 803 810
36. T. Wojcik, E. Szczesny, and S. Chlopicki Detrimental effects of chemotherapeutics and other drugs on the endothelium: a call for endothelial toxicity profiling Pharmacol Rep 67 4 2015 811 817
37. I. Pelikant-Malecka, A. Sielicka, E. Kaniewska, R.T. Smolenski, and E.M. Slominska Endothelial toxicity of unusual nucleotide metabolites Pharmacol Rep 67 4 2015 818 822
38. R. Altschul Endothelium, its development, morphology, function and pathology 1954 The McMillan Company NY